Cardinal Health, Inc.

Good day, and welcome to the Cardinal Health, Inc. Third Quarter Fiscal Year 2020 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Kevin Moran. Please go ahead.

Good morning. This is Kevin Moran, Vice President of Investor Relations. We hope that you and your loved ones are healthy and safe, and we thank you for joining us as we discuss Cardinal Health's Third Quarter Fiscal 2020 results and expectations for the remainder of the fiscal year. Joining me on the call today are Mike Kaufman, Chief Executive Officer, Dave Evans, Interim Chief Financial Officer, and Jason Holler, our incoming Chief Financial Officer. You can find today's press release and presentation on the IR section of our website at ir.cardinalhealth.com. During the call, we will be making forward-looking statements. The matters addressed in the statements are subject to the risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to our SEC filings and the forward-looking statement slide at the beginning of our presentation for a description of these risks and uncertainties. Please note that during the discussion today, our comments will be on a non-GAAP basis unless they are specifically called out as GAAP. Gap to non-gap reconciliations for all relevant periods can be found in the schedules attached to our press release. As far as the agenda for today, Mike will start off by sharing Cardinal Health's response to the COVID-19 pandemic before turning the call over to Dave, who will cover the financials. Jason will briefly introduce himself, and then Mike will share some perspectives on our mid- and longer-term strategies as we navigate this time of tremendous change. The remaining time will be available for your questions. During the Q&A, we kindly ask that you try and limit yourself to one question so that we can try and give everyone an opportunity. With that, I'll now turn the call over to Mike.

Thanks, Kevin. Good morning to everyone joining us. I hope you and your families are safe and well. These past several weeks, we've had a heightened focus on both keeping our Cardinal Health family healthy and safe. and on effectively serving our customers. As one of the largest suppliers of medical and pharmaceutical products, now more than ever, we are committed to fulfilling our mission of supporting healthcare providers and the patients they serve. Keeping our distribution and manufacturing facilities functioning smoothly remains a key priority. To do so, we have implemented measures to protect and retain our frontline employees and maintain the continuity of our operations. And early on, we proactively and successfully implemented remote work policies for office employees. As the pandemic unfolds in different ways and on different timetables around the world, our teams across the company are adapting to new working environments and responding to industry-wide challenges with tenacity, speed, and creativity. Our global manufacturing, procurement, and logistics teams are finding innovative ways to consistently produce and ship medical products. Faced with significantly increased demand for masks, gowns, and other products, our R&D, manufacturing, engineering, quality, and regulatory teams have been working together to increase supply in creative ways. For example, we have invested in retrofitted and redeployed equipment to manufacture additional surgical masks, procedure gowns, and face shields in our North American facilities. We have also repurposed production lines to make items like hand sanitizer and wipes for use in our facilities. We're grateful for the opportunity to serve our communities and healthcare providers, and we are using the full scale and breadth of our distribution sourcing, and manufacturing capabilities to provide essential medical supplies and pharmaceuticals to customers each day. Demand for masks and other facial protection, gowns, and gloves has spiked 2 to 12 times normal levels in the last 90 days. Supporting the delivery of these critical products is a priority for us, and we will continue to do all we can to address these increases in demand. I will share more about how we will continue to navigate this challenging environment to perform our essential role in healthcare. Now I'll turn to Dave to discuss the financials. Thanks, Mike.